Clinical Trial Update: Consolidative Radiotherapy Combined With Camrelizumab and Chemotherapy for Oligometastatic Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating consolidative radiotherapy with camrelizumab and chemotherapy for oligometastatic nasopharyngeal carcinoma; the study is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Camrelizumab (camrelizumab)

Snippet

Sponsor: Jiangxi Provincial Cancer Hospital | Conditions: Oligometastatic Disease | Phase 2 | Status: RECRUITING